What does APOTHEEK LELEU do?

APOTHEEK LELEU is a pharmacy in Menen. Public Limited, started on 24 October 1989, 1 establishment.

What is the address of APOTHEEK LELEU?

The registered office of APOTHEEK LELEU is located at Rijselstraat 222, 8930 Menen.

Is APOTHEEK LELEU still active?

Yes. According to the CBE (30 October 2026) APOTHEEK LELEU is active, legal situation “Normale toestand”, started on 24 October 1989.

Is APOTHEEK LELEU registered on Peppol?

Yes, APOTHEEK LELEU is registered on the Peppol network with ID 0208:0438765939.

What is the enterprise number of APOTHEEK LELEU?

The enterprise number of APOTHEEK LELEU is BE0438765939.

When was APOTHEEK LELEU founded?

APOTHEEK LELEU was founded on 24 October 1989.

Who are the directors of APOTHEEK LELEU?

According to the 2025 annual accounts, the directors of APOTHEEK LELEU are: LUKAVIK BV.

Is APOTHEEK LELEU a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 24 October 1989; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did APOTHEEK LELEU make in 2025?

APOTHEEK LELEU posted a profit after taxes of € 72,652 in financial year 2025.

What is the revenue of APOTHEEK LELEU?

As a small company, APOTHEEK LELEU is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 312,379.

How much does an employee at APOTHEEK LELEU earn?

The average wage cost per full-time employee at APOTHEEK LELEU was € 56,200 in 2025: staff costs of € 101,151 for 1.8 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does APOTHEEK LELEU have?

According to the 2025 annual accounts, APOTHEEK LELEU has 1.8 full-time equivalents (FTE).

APOTHEEK LELEU (Public Limited) - Menen - BE0438765939

Dossier APOTHEEK LELEU, printed on 30 October 2026 from databakkes.be/en/0438765939/apotheek-leleu. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

APOTHEEK LELEU from Menen, company number BE0438765939, closed financial year 2025 with a result of € 72,652 after tax. For that financial year APOTHEEK LELEU recorded a gross margin of € 312,379 and equity of € 522,700. Compared with financial year 2024, the result moved from € 178,916 to € 72,652. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on December 22, 2025.

What it is worth Growing

€ 522,700

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 72,652

▼ 59% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 229,881

▲ 7% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 72,000 paid out

99 % of the profit went to the shareholders, mostly to LUKAVIK (100 % of the shares). That is where the money ends up.

People and assets in 2025

Full-time equivalents

1.8

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 101,151

▲ 4% vs 2024

€ 56,200 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 46,701

▼ 26% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 5 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 230,046

▼ 17% vs 2024

€ 46,542 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.

Owed to suppliers

€ 71,220

▲ 85% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 11,318

▼ 13% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 291,833 Gross margin 2022: € 291,833 First fiscal year in the series	€ 287,580 Gross margin 2023: € 287,580 ▼ 1% vs 2022 (€ 291,833) Unfavourable step	€ 334,933 Gross margin 2024: € 334,933 ▲ 16% vs 2023 (€ 287,580) Favourable step	€ 312,379 Gross margin 2025: € 312,379 ▼ 7% vs 2024 (€ 334,933) Unfavourable step	▼ 7%
Profit after taxes	€ 157,010 Profit after taxes 2022: € 157,010 First fiscal year in the series	€ 148,461 Profit after taxes 2023: € 148,461 ▼ 5% vs 2022 (€ 157,010) Unfavourable step	€ 178,916 Profit after taxes 2024: € 178,916 ▲ 21% vs 2023 (€ 148,461) Favourable step	€ 72,652 Profit after taxes 2025: € 72,652 ▼ 59% vs 2024 (€ 178,916) Unfavourable step	▼ 59%
Equity	€ 435,422 Equity 2022: € 435,422 First fiscal year in the series	€ 521,883 Equity 2023: € 521,883 ▲ 20% vs 2022 (€ 435,422) Favourable step	€ 522,049 Equity 2024: € 522,049 Unchanged (€ 521,883) Favourable step	€ 522,700 Equity 2025: € 522,700 Unchanged (€ 522,049) Favourable step
Total debts	€ 353,811 Total debts 2022: € 353,811 First fiscal year in the series	€ 372,000 Total debts 2023: € 372,000 ▲ 5% vs 2022 (€ 353,811) Unfavourable step	€ 506,494 Total debts 2024: € 506,494 ▲ 36% vs 2023 (€ 372,000) Unfavourable step	€ 385,578 Total debts 2025: € 385,578 ▼ 24% vs 2024 (€ 506,494) Favourable step	▼ 24%
Cash	€ 141,596 Cash 2022: € 141,596 First fiscal year in the series	€ 205,128 Cash 2023: € 205,128 ▲ 45% vs 2022 (€ 141,596) Favourable step	€ 215,562 Cash 2024: € 215,562 ▲ 5% vs 2023 (€ 205,128) Favourable step	€ 229,881 Cash 2025: € 229,881 ▲ 7% vs 2024 (€ 215,562) Favourable step	▲ 7%
Retained profit	€ 373,422 Retained profit 2022: € 373,422 First fiscal year in the series	€ 459,883 Retained profit 2023: € 459,883 ▲ 23% vs 2022 (€ 373,422) Favourable step	€ 460,049 Retained profit 2024: € 460,049 Unchanged (€ 459,883) Favourable step	€ 460,700 Retained profit 2025: € 460,700 Unchanged (€ 460,049) Favourable step
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 62,000 Dividend 2023: € 62,000 Unchanged (€ 0) Unchanged	€ 178,750 Dividend 2024: € 178,750 ▲ 188% vs 2023 (€ 62,000) Unchanged	€ 72,000 Dividend 2025: € 72,000 ▼ 60% vs 2024 (€ 178,750) Unchanged	▼ 60%
Bank debt	€ 297,500 Bank debt 2022: € 297,500 First fiscal year in the series	€ 262,500 Bank debt 2023: € 262,500 ▼ 12% vs 2022 (€ 297,500) Favourable step	€ 276,308 Bank debt 2024: € 276,308 ▲ 5% vs 2023 (€ 262,500) Unfavourable step	€ 230,046 Bank debt 2025: € 230,046 ▼ 17% vs 2024 (€ 276,308) Favourable step	▼ 17%
Balance sheet total	€ 789,233 Balance sheet total 2022: € 789,233 First fiscal year in the series	€ 893,882 Balance sheet total 2023: € 893,882 ▲ 13% vs 2022 (€ 789,233) Unchanged	€ 1,028,543 Balance sheet total 2024: € 1,028,543 ▲ 15% vs 2023 (€ 893,882) Unchanged	€ 908,279 Balance sheet total 2025: € 908,279 ▼ 12% vs 2024 (€ 1,028,543) Unchanged	▼ 12%
Employees (FTE)	1.8 Employees (FTE) 2022: 1.8 First fiscal year in the series	1.8 Employees (FTE) 2023: 1.8 Unchanged (1.8) Unchanged	1.8 Employees (FTE) 2024: 1.8 Unchanged (1.8) Unchanged	1.8 Employees (FTE) 2025: 1.8 Unchanged (1.8) Unchanged

Key figures of APOTHEEK LELEU, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.

What happened to APOTHEEK LELEU?

What happened at APOTHEEK LELEU in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Dec 22, 2025 New annual accounts for financial year 2025: profit of € 72,652 (▼ 59% vs 2024). Source: NBB ↗
Nov 24, 1989 New establishment in Menen. KBO
Oct 24, 1989 Start of the company according to the CBE. KBO

In short

From € 157,010 profit in 2022 to € 72,652 profit in 2025.

Paid € 3,106 in corporate taxes since 2022.

Best year ever: 2024, with € 178,916 profit.

On average € 173,500 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

LUKAVIK 100%

The stake of LUKAVIK comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

APOTHEEK LELEU

Behind APOTHEEK LELEU is LUKAVIK BV. The shares are held by LUKAVIK (100%).

Directors

According to the 2025 annual accounts

LUKAVIK BV

Director · represented by Leleu JOHAN

Also active at: Ipharma

Shareholders

LUKAVIK

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Rijselstraat 222

8930 Menen

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0438.765.939

VAT number

BE 0438.765.939

Registered office

Rijselstraat 222, 8930 Menen

Names & denominations

APOTHEEK LELEU

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

24 October 1989

Peppol

Active · Active since 10 Dec 2025

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

Vervaardiging van geneesmiddelen

View on CBE Public ↗ Annual accounts (NBB) ↗

APOTHEEK LELEU

Financials

What happened to APOTHEEK LELEU?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Details

Frequently asked questions